![Ken Warrington](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Warrington
Direktor/Vorstandsmitglied bei
BIOSTEM TECHNOLOGIES, INC.
Vermögen: 22 361 $ am 30.06.2026
Profil
Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2025 | 6 776 ( 0,04 % ) | 22 361 $ | 30.06.2026 |
Aktive Positionen von Ken Warrington
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSTEM TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.03.2022 |
Ehemalige bekannte Positionen von Ken Warrington
| Unternehmen | Position | Ende |
|---|---|---|
GENSCRIPT PROBIO USA INC.
 GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | Corporate Officer/Principal | 01.12.2021 |
Biostem Life Sciences, Inc. | Geschäftsführer | 01.05.2020 |
Lacerta Therapeutics, Inc.
 Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
Ausbildung von Ken Warrington
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioStem Technologies, Inc.
 BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
The St. Lawrence College
 The St. Lawrence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | |
Biostem Life Sciences, Inc. |
